Concepedia

Carlos Panizo

CP

Statistics

Publications

64

Citations

3.3K

H-Index

32

Active since

1993

Affiliations

Clinica Universidad de Navarra(Current)

Universidad de Navarra

Hospital Del Mar

Hospital Universitari Germans Trias i Pujol

Universidad de Salamanca

Carlos Panizo is an author at Clinica Universidad de Navarra specializing in medicine, oncology, and immunotherapy.

ORCID

Publications per year

1993–2024

64

Publications

64

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Michael Wang, Simon Rule, Pier Luigi Zinzani et al. · The Lancet · 2017 · 448 citations · Full text

, , +11

Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry

Sandra Quijano, Antonio López, Juan‐Manuel Sancho et al. · Journal of Clinical Oncology · 2009 · 215 citations · Full text

, , +17

The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma

Laura Moreno, Cristina Pérez, Aintzane Zabaleta et al. · Clinical Cancer Research · 2019 · 215 citations · Full text

, , +17

Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma

Susana Inogés, Mercedes Rodrı́guez-Calvillo, Natalia Zabalegui et al. · JNCI Journal of the National Cancer Institute · 2006 · 149 citations · Full text

, , +17

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma

Jose A. Richter-Larrea, Eloy F. Robles, Vicente Fresquet et al. · Blood · 2010 · 110 citations · Full text

, , +14

1–5 of 64